Related Experiment Video
Updated: Feb 19, 2026

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
Risk factors for psychological and psychosomatic symptoms among children with malignancies
Kenichi Maeda1, Daisuke Hasegawa1, Kevin Y Urayama2
1Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
Insights
Children with cancer experiencing psychological and psychosomatic symptoms (PPS) requiring medication are more likely to be older, receive opioids, or undergo hematopoietic stem cell transplantation (HSCT). These findings highlight key risk factors for PPS in pediatric oncology patients.
Area of Science:
- Pediatric Oncology
- Child Psychology
- Hematology
Background:
- Increasing survival rates in pediatric malignancies necessitate greater focus on quality-of-life.
- Psychological and psychosomatic symptoms (PPS) are a significant concern for hospitalised children with cancer.
Purpose of the Study:
- To identify factors associated with psychological and psychosomatic symptoms (PPS) requiring medication in children undergoing cancer treatment.
- To inform preventive strategies for PPS in pediatric oncology.
Main Methods:
- Retrospective analysis of 190 patients aged 2-18 years diagnosed with malignancies.
- Data collected from St. Luke's International Hospital between 2003 and 2013.
- PPS defined by prescription of psychotropic agents during hospitalisation.
Main Results:
- 30% of patients (56/190) received psychotropic agents for PPS, including insomnia and anxiety.
- Multivariable analysis identified hematopoietic stem cell transplantation (HSCT) (OR, 5.21), older age (12-18 years vs. 2-5 years, OR, 3.74), and opioid use (OR, 7.15) as independent risk factors.
- Etizolam was the most prescribed psychotropic agent.
Conclusions:
- Older age, HSCT, and opioid use are significant risk factors for PPS in children with malignancies.
- Targeted preventive measures are recommended for pediatric cancer patients with these identified risk factors.
- Further research into the specific mechanisms and interventions for PPS in this population is warranted.
Aim:
With increasing survival rates in paediatric malignancies, the quality-of-life of children during hospitalisation should be given more attention. We aimed to identify factors associated with psychological and psychosomatic symptoms (PPS) that required medication among children hospitalised for treatment of malignancies.
Methods:
We retrospectively analysed data of 190 patients aged 2-18 years old. They were diagnosed with malignant diseases and admitted for treatment at St. Luke's International Hospital between 2003 and 2013. Patients were considered as having PPS if they were prescribed psychotropic agents during hospitalisation.
Results:
Of the 190 patients, 56 (30%) were prescribed psychotropic agents for PPS. Types of PPS included insomnia in 21 (38%), anxiety in 11 (20%), and others conditions (psychogenetic nausea, agitation, delirium, depression). The most prescribed psychotropic agents were etizolam for 34 cases (61%), followed by diazepam and risperidone. The multivariable analyses confirmed statistically significant independent associations for haematopoietic stem cell transplantation (HSCT) (odds ratio (OR), 5.21; 95% confidence interval (CI), 1.77-15.35), older age (12-18 years vs. 2-5 years, OR, 3.74; 95% CI, 1.04-10.00), and opioid use (OR, 7.15; 95% CI, 2.36-21.69).
Conclusions:
Older age at admission, undergoing HSCT, and those given opioids were found to be risk factors for PPS among children with malignancies. Appropriate preventive measures against PPS may be warranted for patients with these risk factors.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Psychoneuroimmunology: Diabetes and Cancer
Cancer Prevention
Some...
Bullying
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...